1 of 1
Story summary
- A bipartisan group of U.S. senators agreed to cap the price of a month's insulin supply at $35.
- Senator Jeanne Shaheen (D-N.H.) is leading the effort before her retirement and is working with Senators Susan Collins, Raphael Warnock, and John Kennedy.
- Semafor reported on March 25, 2026, that the deal aims to reduce insulin costs.
